Advanced BioMedical Technologies, Inc. Exchange Rate Effect on Cash
Advanced BioMedical Technologies, Inc. reported Exchange Rate Effect on Cash of $6.05 thousand for the 9-month period ending 2021-07-31, per its 10-Q filed 2021-09-13.
Discontinued › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations · last filed 2021-09-13
- Advanced BioMedical Technologies, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for the quarter ending 2021-01-31 was $4.70K, a 6252.70% increase year-over-year.
- Advanced BioMedical Technologies, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for the quarter ending 2020-01-31 was $74.00, a 72.89% decline year-over-year.
- Advanced BioMedical Technologies, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for the quarter ending 2019-01-31 was $273.00, a 57.28% decline year-over-year.
- Advanced BioMedical Technologies, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for the quarter ending 2018-01-31 was $639.00.
- Advanced BioMedical Technologies, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for fiscal 2020 was $7.94K.
- Advanced BioMedical Technologies, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for fiscal 2019 was -$15.00.
- Advanced BioMedical Technologies, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for fiscal 2018 was -$57.00, a 154.29% decline from fiscal 2017.
- Advanced BioMedical Technologies, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for fiscal 2017 was $105.00.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations 3 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations 6 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations 9 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations 12 month |
|---|---|---|---|---|
| 2021-07-31 | $6.05K 10-Q · filed 2021-09-13 | |||
| 2021-04-30 | $5.29K 10-Q · filed 2021-06-21 | |||
| 2021-01-31 | $4.70K 10-Q · filed 2021-03-22 | |||
| 2020-10-31 | $7.94K 10-K · filed 2021-01-29 | |||
| 2020-07-31 | $111.00 10-Q · filed 2021-09-13 | |||
| 2020-04-30 | -$50.00 10-Q · filed 2021-06-21 | |||
| 2020-01-31 | $74.00 10-Q · filed 2021-03-22 | |||
| 2019-10-31 | -$15.00 10-K · filed 2021-01-29 | |||
| 2019-07-31 | -$37.00 10-Q · filed 2020-09-21 | |||
| 2019-04-30 | $110.00 10-Q · filed 2020-06-22 | |||
| 2019-01-31 | $273.00 10-Q/A · filed 2020-08-20 | |||
| 2018-10-31 | -$57.00 10-K · filed 2020-03-20 | |||
| 2018-07-31 | -$363.00 10-Q · filed 2019-09-20 | |||
| 2018-04-30 | $117.00 10-Q · filed 2019-06-19 | |||
| 2018-01-31 | $639.00 10-Q · filed 2019-04-01 | |||
| 2017-10-31 | $105.00 10-K/A · filed 2019-03-29 |